Jason A. Keyes

Chief Financial Officer

Chief Financial Officer at BlossomHill Therapeutics, Inc., filing insider transactions on 2026-08-10.

Total Purchases

$11K

1 transaction

Total Sales

—

0 transactions

Companies Traded

1 total filings

Active Since

2026-08-10

Last: 2026-08-10

Companies

BlossomHill Therapeutics, Inc.

Date	Ticker	Type	Shares	Price	Value	Owned After
2026-08-10	BLSM	Purchase	700	$16.00	$11K	700	SEC ↗